Newbury Pharmaceuticals ABNEWBRY 
$0.31-1.89%24h
-1.89%24h
Global rank34107
Market cap$5.98M
Change 7d0.65%
YTD Performance-0.64%
SP500 benchmarkUnderperform
P/E-0.31
P/S5.93
Revenue$1.01M
Earnings-$1.91M
Dividend yield-
Main Sector
Healthcare
Newbury Pharmaceuticals AB (NEWBRY) Net Assets
NEWBRY Net Assets in 2023: $49.38M
As of 18 Sept 2024, Newbury Pharmaceuticals AB net assets is $49.38M, an decrease of -28.20% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Newbury Pharmaceuticals AB overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Newbury Pharmaceuticals AB Net Assets History from 2021 to 2024
-
Value:-
NEWBRY Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $49.38M | -28.20% |
| 2022 | $68.77M | 78.77% |
| 2021 | $38.47M | - |
View the Top Net Assets Companies
